3[1]Lobo RA.Treatment of the postmenopausal women:basic and clinical aspects.2nd ed.Philadelphia,USA:Lippincott Williams & Wilhins,1999.331
4[2]Grady D.Cardiovascular disease outcomes during 6.8 years of hormone therapy for heart and estrogen/progestin replacement study follow-up (HERS Ⅱ).JAMA,2002, 288: 49
5[3]Hulley S, Grady D, Bush T,et al.Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA,1998, 280:605
6[4]Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA,2002, 288:321
8Terry PD,Abramson JL,Neaton JD,et al.Blood pressure and risk of death from external causes among men screened for the Multiple Risk Factor Intervention Trial[J].Am J Epidemiol.2007,165(3):294-301.
9J Mufunda,G Mebrahtu,A Usman,et al,The prevalence of hypertension and its relationship with obesity:results from a national blood pressure survey in Eritrea[J].Human Hypertension,2006,20(1):59-65.
10Jan AS,Jiguang W,Giuseppe B. Essential hypertension[J].Lancet,2003,(9369):1629-1641.
